Licensing Cambridge innovation
Cambridge Enterprise works in collaboration with University of Cambridge researchers to market and license available technologies ranging from the biosciences to engineering.
We have completed more than 1,000 commercial agreements.
We welcome contact from companies interested in licensing available technologies from the University of Cambridge, and work with companies on an individual basis to identify specific areas of interest.
Image: The chromosome screening technology developed by University of Cambridge spin-out BlueGnome has shown to increase in vitro fertilisation (IVF) success rates by 65% over the current methods.